Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Proteomic profiling of antibody-drug conjugate (ADC) biomarkers in pancreatic cancer.
Authors
Sheeno P. Thyparambil
mProbe Inc., Rockville, MD;
Sheeno P. Thyparambil , Wei-Li Liao , Robert Heaton , Amanda Strasbaugh , Marya Abebe Melkie , Xuefeng Ling
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Diagnostics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 671)
DOI
10.1200/JCO.2023.41.4_suppl.671
Abstract #
671
Poster Bd #
H15
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Expression of antibody-drug conjugates (ADC) biomarkers in colorectal cancer.
First Author: Sheeno P. Thyparambil
First Author: Rebecca Feldman
Poster
2020 ASCO Virtual Scientific Program
Proteomic profiling to identify therapeutics targets in glioblastoma (GBM).
First Author: Sheeno P. Thyparambil
Poster
2018 Gastrointestinal Cancers Symposium
Second-line treatment of modified FOLFIRINOX or nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma.
First Author: Masato Ozaka